Incidence, clinical features and management of hypersensitivity reactions to chemotherapeutic drugs in children with cancer Antonio RuggieroSilvia TriaricoRiccardo Riccardi Review Article 14 June 2013 Pages: 1739 - 1746
Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study L. FrankensteinH. A. Katuson behalf of the Norwegian Heart Failure Registry steering committee Clinical Trial 07 June 2013 Pages: 1747 - 1755
Survey of users of TOPS, an internet-based system to prevent healthy subjects from over-volunteering for clinical trials M. BoyceM. WaltherS. Warrington Clinical Trial 07 June 2013 Pages: 1757 - 1760
Preladenant, a selective adenosine A2A receptor antagonist, is not associated with QT/QTc prolongation Z. WangF. XuanD. L. Cutler Clinical Trial 16 July 2013 Pages: 1761 - 1767
Cytochrome P450 oxidoreductase genetic polymorphisms A503V and rs2868177 do not significantly affect warfarin stable dosage in Han-Chinese patients with mechanical heart valve replacement Sheng-Lan TanZhi LiHong-Hao Zhou Pharmacogenetics 16 August 2013 Pages: 1769 - 1775
Influence of chronic hepatitis C infection on cytochrome P450 3a4 activity using midazolam as an in vivo probe substrate P. N. MorcosS. A. MoreiraP. F. Smith Pharmacokinetics and Disposition 14 June 2013 Pages: 1777 - 1784
Interaction of ambrisentan with clarithromycin and its modulation by polymorphic SLCO1B1 Christoph MarkertRegina HellwigWalter E. Haefeli Pharmacokinetics and Disposition 09 June 2013 Pages: 1785 - 1793
Concentration effect relationship of CYP3A inhibition by ritonavir in humans Christine EichbaumMarianna CorteseGerd Mikus Pharmacokinetics and Disposition 09 June 2013 Pages: 1795 - 1800
A pharmacokinetic interaction study of ticagrelor and digoxin in healthy volunteers Renli TengKathleen Butler Pharmacokinetics and Disposition 09 June 2013 Pages: 1801 - 1808
Meta-analyses of dose-exposure relationships for gabapentin following oral administration of gabapentin and gabapentin enacarbil Chao Chen Pharmacokinetics and Disposition 07 June 2013 Pages: 1809 - 1817
Spontaneous reporting of serious cutaneous reactions with protein kinase inhibitors Emmanuelle FayeEmmanuelle Bondon-GuittonThe French Network of Regional Pharmacovigilance Centers Pharmacoepidemiology and Prescription 09 June 2013 Pages: 1819 - 1826
Associations between generic substitution and patients' attitudes, beliefs and experiences Jette RathePia LarsenJens Soendergaard Pharmacoepidemiology and Prescription 14 June 2013 Pages: 1827 - 1836
Adherence to hospital drug formularies and cost of drugs in hospitals in Denmark Hanne T. PletJesper HallasLene J. Kjeldsen Pharmacoepidemiology and Prescription 14 June 2013 Pages: 1837 - 1843
Compliance with quality prescribing indicators in terms of their relationship to financial incentives Rocío Fernández UrrusunoMa Carmen Montero BalosaBeatriz Pascual de la Pisa Pharmacoepidemiology and Prescription 07 June 2013 Pages: 1845 - 1853
Statins are associated with reduced risk of gastric cancer: A meta-analysis Xiao-Dan WuKai ZengYan-Qing Chen Pharmacoepidemiology and Prescription 09 June 2013 Pages: 1855 - 1860
Pharmacokinetic interaction between tacrolimus and berberine in a child with idiopathic nephrotic syndrome Qian HouWeidong HanXiaobing Fu Letter to the Editors 14 June 2013 Pages: 1861 - 1862